Rankings
▼
Calendar
AQST Q1 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$424M
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$16M
Gross Profit
$12M
74.5% margin
Operating Income
$781,000
4.8% margin
Net Income
-$1M
-8.9% margin
EPS (Diluted)
$-0.07
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$3M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
-$18M
Cash & Equivalents
-$9M
← FY 2017
All Quarters
Q2 2017 →
